UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine
The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on Thursday. Medicines and Healthcare products Regulatory Agency's (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month
View the full story here: https://www.reuters.com/world/uk/uk-adds-nerve-disorder-rare-side-effect-astrazeneca-covid-19-vaccine-2021-10-21/